Showing results (541-550 of 688) with videos related to

Sort By:
Pageof 69
Plos One|December 10, 2025
New investigations of the Hjortspring boat: Dating and analysis of the cordage and caulking materials used in a pre-Roman iron age plank boatMikael Fauvelle, Boel Bengtsson, Olof Pipping, et al.
Lancet (London, England)|June 18, 2018
Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trialMark C Genovese, Roy Fleischmann, Bernard Combe, et al.
RMD Open|September 29, 2017
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumabGerd R Burmester, Gurjit S Kaeley, Arthur F Kavanaugh, et al.
The New England Journal of Medicine|October 1, 2015
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic ArthritisPhilip J Mease, Iain B McInnes, Bruce Kirkham, et al.
RMD Open|March 13, 2024
Impact of filgotinib on pain control in the phase 3 FINCH studiesPeter C Taylor, Arthur Kavanaugh, Peter Nash, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2024
Effect of Intravenous Zoledronic Acid on Total Knee Replacement in Patients With Symptomatic Knee Osteoarthritis and Without Severe Joint Space Narrowing: A Prespecified Secondary Analysis of a Two-Year, Multicenter, Double-Blind, Placebo-Controlled Clinical TrialGuoqi Cai, Laura L Laslett, Michael Thompson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 3, 2021
Recreational Physical Activity and Risk of Incident Knee Osteoarthritis: An International Meta-Analysis of Individual Participant-Level DataLucy S Gates, Thomas A Perry, Yvonne M Golightly, et al.
ACR Open Rheumatology|October 4, 2024
Persistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2-Year, Phase 3, Randomized, Controlled StudyPhilip J Mease, Xenofon Baraliakos, Vinod Chandran, et al.
Rheumatology (Oxford, England)|October 19, 2017
Remission in psoriatic arthritis-where are we now?Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, et al.
The Journal of Rheumatology|December 17, 2015
Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD TrialEdward C Keystone, Mark C Genovese, Stephen Hall, et al.
Pageof 69